Clomipramine: Clinical Trials

18 trials of Clomipramine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 2 terminated, 2 unknown, 1 not yet recruiting. 4 Not applicable, 4 Phase 2, 4 Phase 4, 3 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 3, Unknown 1
Phase 24Completed 3, Unknown 1
Phase 44Completed 2, Not yet recruiting 1, Terminated 1
Phase 13Completed 3
Phase 33Completed 2, Terminated 1

Follow Clomipramine: new trials by email Literature Review of Clomipramine trials Research Report on Clomipramine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Hydroxyzine for Patients With Panic Disorder
Hydroxyzine, Escitalopram Oxalate - Panic Disorder
Phase 4Not yet recruitingSultan Qaboos University802023-12-302023-02-21
Pharmacovigilance in Gerontopsychiatric Patients
Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression
Phase 3TerminatedHannover Medical School4072015-01-012018-02-28
Drug-Drug Interaction of Clomipramine HCl and Sildenafil Citrate in Healthy Males
Treatment 1, Treatment 2, Treatment 3 - Healthy
Phase 1CompletedCTC Bio, Inc.302014-01-012014-09-15
Interpersonal Psychotherapy for Treatment Resistant Depression
IPT+ antidepressant drugs, fluoxetine, sertraline - Treatment Resistant Depression
Not applicableUnknownHospital de Clinicas de Porto Alegre742013-04-012013-07-11
Trial of PED-1 in Male Patients With Premature Ejaculation
Clomipramine - Premature Ejaculation
Phase 3CompletedSymyoo1592011-09-012012-10-03
Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation
Clomipramine - Premature Ejaculation
Phase 2CompletedSymyoo1042010-09-012012-10-03
Efficacy of Antidepressants in Chronic Back Pain
cognitive behavioral therapy, desipramine hydrochloride, benztropine mesylate 0.125 mg daily - Back Pain
Phase 2CompletedVA Office of Research and Development1422010-01-012016-11-29
Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major Depression
C-ECT, PHARMACOTHERAPY - Depression
Phase 4TerminatedHospital Universitari de Bellvitge1042009-07-012015-08-31
Assessment of Pituitary Adenylate Cyclase Activating Polypeptide-Brain Derived Neurotrophic Factor (PACAP-BDNF) Signaling System Involvement in Etiology and Treatment of Major Depression
SSRI; SNRI; TCA - Major Depression
Not applicableCompletedTirat Carmel Mental Health Center1002009-06-012012-07-26
Predicting Medication Response in Obsessive Compulsive Disorder
clomipramine, escitalopram, duloxetine - Obsessive Compulsive Disorder
Not applicableCompletedSunnybrook Health Sciences Centre262009-04-012013-01-31
Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous Treatment
Clomipramine (fluoxetine plus clomipramine), Quetiapine (fluoxetine plus quetiapine), Placebo (fluoxetine plus placebo) - Obsessive Compulsive Disorder
Phase 4CompletedUniversity of Sao Paulo542007-05-012017-10-30
Quetiapine Augmentation Versus Clomipramine Augmentation of SSRI for Obsessive-compulsive Disorder Patients
Quetiapine, Clomipramine - Obsessive Compulsive Disorder
Phase 4CompletedUniversity of Sao Paulo212006-01-012017-10-27
Treatment of Obsessive Compulsive Disorder in Children
Serotonin reuptake inhibitors management, Cognitive behavioral therapy by a psychologist, Instructional cognitive behavioral therapy by a psychiatrist - Obsessive-Compulsive Disorder
Phase 3CompletedDuke University1242003-09-012014-07-29
Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients With Obsessive Compulsive Disorder
Clomipramine - Obsessive-Compulsive Disorder
Phase 2UnknownNational Center for Research Resources (NCRR)761999-10-012005-06-24
Effect of Antidepressants on Back Pain
Desipramine, Fluoxetine, Benztropine - Back Pain, Sciatica
Phase 2CompletedUS Department of Veterans Affairs1301999-04-012012-06-05
Citalopram vs Clomipramine vs Placebo in Recurrent Depression
Citalopram, Clomipramine, placebo - Depression
Not applicableCompletedUniversity of Aarhus591997-10-012012-04-11
To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed and Fasted Conditions
Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fasting Conditions, Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions, Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions - Depression
Phase 1CompletedSandoz181994-04-012017-03-28
To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fasted Conditions
Clomipramine Hydrochloride 25 mg Capsules (Geneva Pharmaceuticals), Anafranil Clomipramine Hydrochloride 25 mg Capsules (Basel) - Depression
Phase 1CompletedSandoz361992-11-012017-03-28

Conditions studied

Depression (6)  ·  Obsessive-Compulsive Disorder (5)  ·  Premature Ejaculation (3)  ·  Anxiety Disorders (2)  ·  Back Pain (2)  ·  Agnosia (1)  ·  Chronic Pain (1)  ·  Dementia (1)  ·  Depressive Disorder, Major (1)  ·  Depressive Disorder, Treatment-Resistant (1)  ·  Mental Disorders (1)  ·  Neurologic Manifestations (1)  ·  Panic Disorder (1)  ·  Psychophysiologic Disorders (1)  ·  Rare Diseases (1)

Sponsors

Sandoz (2)  ·  Symyoo (2)  ·  University of Sao Paulo (2)  ·  CTC Bio, Inc. (1)  ·  Duke University (1)  ·  Hannover Medical School (1)  ·  Hospital Universitari de Bellvitge (1)  ·  Hospital de Clinicas de Porto Alegre (1)  ·  National Center for Research Resources (NCRR) (1)  ·  Sultan Qaboos University (1)  ·  Sunnybrook Health Sciences Centre (1)  ·  Tirat Carmel Mental Health Center (1)  ·  US Department of Veterans Affairs (1)  ·  University of Aarhus (1)  ·  VA Office of Research and Development (1)

Countries

United States (4)  ·  Brazil (3)  ·  South Korea (3)  ·  Canada (1)  ·  Germany (1)  ·  Israel (1)  ·  Spain (1)

Top investigators

Juliana B Diniz, MD (2)  ·  Richard Lalonde, Pharm.D. (2)  ·  Albert Pinhasov, PhD (1)  ·  Anatoly Kreinin, MD, PhD (1)  ·  Helge Frieling, Prof., MD (1)  ·  John S March, MD MPH (1)  ·  Joseph Farah, MD (1)  ·  Joseph H Atkinson, MD (1)  ·  Joseph H. Atkinson, MD (1)  ·  Kamal Farhat, MD (1)  ·  Klaudia Rybalksy, MD (1)  ·  Leon Raskin, PhD (1)  ·  Lorrin Koran (1)  ·  Marcelo PA Fleck, MD,PhD (1)  ·  Mikel Urretavizcaya Sarachaga, MD, PhD (1)

Results publications

PMID 17414235, PMID 19183470, PMID 19578654, PMID 21934055, PMID 22020357, PMID 25457929, PMID 26799332, PMID 28412602, PMID 32068667

NIH funding

2005 (2), R01MH055121 (1)